Research Article
Endothelial Dysfunction, a Marker of Atherosclerosis, Is Independent of Metabolic Syndrome in NAFLD Patients
Table 2
Baseline clinical, anthropometrical, and biochemical comparison between NAFLD with MS and NAFLD without MS.
| Parameters | NAFLD with MS () | NAFLD without MS () | value |
| Age | | | 0.11 | BMI | | | <0.001 | Waist circumference | | | <0.001 | Waist/hip ratio | | | <0.001 | Waist/height ratio | | | <0.001 | SBP | | | <0.001 | DBP | | | 0.17 | Total bilirubin | | | 0.16 | AST | | | 0.25 | Alkaline phosphatase | | | 0.001 | Total protein | | | 0.125 | Albumin | | | 0.358 | Globulin | | | 0.42 | GGT | | | 0.03 | Insulin | | | <0.001 | HOMA IR | | | <0.001 | FBS | | | 0.002 | 2hour PPBS | | | 0.001 | Triglycerides | | | 0.033 | Total cholesterol (TC) | | | 0.913 | HDL | | | 0.008 | LDL | | | 0.558 | VLDL | | | 0.073 | LDL/HDL | | | 0.629 | TC/HDL | | | 0.06 |
|
|